Division of Pharmacology and Toxicology, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.
Division of Medicine, ICAR-Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India.
J Biochem Mol Toxicol. 2022 Aug;36(8):e23090. doi: 10.1002/jbt.23090. Epub 2022 May 2.
The present study was undertaken to investigate the safety of kaempferol (KEM) and biochanin-A (BCA) following subacute exposure in mice. KEM and BCA were administered in three different doses by oral administration for 28 days. Evaluation of general toxicity parameters by examining the clinical signs, body weight, organ weights, haematological, biochemical, oxidative stress parameters, and histopathology was done. Administration of KEM and BCA for 28 days did not show any clinical signs of toxicity, nor any treatment-related changes in body weight and organ weights in comparison to control. The haematological parameters such as red blood cell, white blood cell, platelets count, haemoglobin (Hb) level, haematocrit, mean corpuscular haemoglobin concentration, red cell distribution width, and platelet distribution width did not show any change in the treated groups and control. Furthermore, different biochemical parameters like markers of the liver (alanine aminotransferase and aspartate aminotransferase), kidney (creatinine and urea), and heart (creatinine kinase-myocardial band and lactate dehydrogenase) injury along with other biochemical parameters showed nonsignificant differences between treated groups and control. Results of oxidative stress parameters in treated groups showed insignificant variations with control. The level of antioxidant enzymes such as superoxide dismutase and catalase were markedly increased in the treated groups; however, these were nonsignificant in comparison to control. In histopathology, evaluation of all vital organs, such as liver, kidney, heart, and lungs, did not show any morphological abnormalities and lesions in treated groups and control. The present study suggests that KEM and BCA have no adverse effects on the general physiology in mice.
本研究旨在调查山奈酚(KEM)和大豆苷元(BCA)在亚急性暴露于小鼠后的安全性。通过口服给予 KEM 和 BCA 三种不同剂量,连续 28 天。通过检查临床症状、体重、器官重量、血液学、生化、氧化应激参数和组织病理学来评估一般毒性参数。与对照组相比,KEM 和 BCA 连续 28 天给药未显示任何毒性的临床症状,也未显示任何与体重和器官重量相关的变化。血液学参数如红细胞、白细胞、血小板计数、血红蛋白(Hb)水平、血细胞比容、平均红细胞血红蛋白浓度、红细胞分布宽度和血小板分布宽度在治疗组和对照组均未发生变化。此外,不同的生化参数,如肝脏(丙氨酸氨基转移酶和天冬氨酸氨基转移酶)、肾脏(肌酐和尿素)和心脏(肌酸激酶-心肌带和乳酸脱氢酶)损伤的标志物以及其他生化参数在治疗组和对照组之间均无显著差异。治疗组氧化应激参数的结果与对照组相比无明显变化。超氧化物歧化酶和过氧化氢酶等抗氧化酶的水平在治疗组明显升高;然而,与对照组相比,这些变化并不显著。在组织病理学方面,对所有重要器官(如肝脏、肾脏、心脏和肺)的评估未显示治疗组和对照组有任何形态异常和病变。本研究表明,KEM 和 BCA 对小鼠的一般生理没有不良影响。